Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco WilderHill Clean Energy ETF (PBW) vs GeneDx Holdings Corp (WGS) Price & Performance

Invesco WilderHill Clean Energy ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Invesco WilderHill Clean Energy ETF vs GeneDx Holdings Corp — how do they compare? Invesco WilderHill Clean Energy ETF trades at $31.54, while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). Which is the better fit depends on your goals.

PBWWGS
Sector
Sector/ThematicTechnology
52-Week High
$46.99$167.51
52-Week Low
$24.75$34.51
Market Cap
$2.56B
Enterprise Value
$2.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco WilderHill Clean Energy ETF

PBW (Invesco WilderHill Clean Energy ETF) trades at $32.38, up 1.86% today, but technical indicators show a bearish trend with moving averages signaling selling pressure. The ETF's unique selection criteria focusing on ecological factors over financial metrics creates an undiversified portfolio that has underperformed broader markets. Recent market volatility from geopolitical tensions and tech sector sell-offs has impacted clean energy ETFs despite long-term growth catalysts.

The clean energy sector faces near-term headwinds from market volatility, though long-term prospects remain supported by global energy security concerns and substantial international investment. PBW's performance remains tied to clean energy adoption trends and policy developments, with current technical weakness suggesting cautious near-term positioning.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Returns comparison

Trailing returns across standard periods

About Invesco WilderHill Clean Energy ETF

PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.

Read more on PBW

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS